Invention Publication
- Patent Title: PHARMACEUTICAL AEROSOL PRODUCT FOR ADMINISTRATION BY ORAL OR NASAL INHALATION
-
Application No.: US18425676Application Date: 2024-01-29
-
Publication No.: US20240226006A1Publication Date: 2024-07-11
- Inventor: Helgert Müller , Renate Engelstätter , Ulrich Bildmann , Andrea Bauer , Paul McGlynn
- Applicant: Covis Pharma GmbH
- Applicant Address: CH Zug
- Assignee: Covis Pharma GmbH
- Current Assignee: Covis Pharma GmbH
- Current Assignee Address: CH Zug
- Priority: EP 178042.5 2011.08.19
- Main IPC: A61K9/12
- IPC: A61K9/12 ; A61K9/00 ; A61K31/58 ; A61M11/04 ; A61M15/00
Abstract:
This invention relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children. The aerosol composition comprises ciclesonide, ethanol and either 1,1,1,2-tetrafluoroethane, or 1,1,1,2,3,3,3-heptafluoropropane.
Information query
